FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

A highly sensitive test that detects traces of disease in the bone marrow of patients with a rare and aggressive type of blood cancer could help double their chances of survival, a first-of-its-kind ...

Why might you have a bone marrow test? You have a bone marrow test to check whether there are cancer cells in your bone marrow. Bone marrow is spongy tissue and fluid that is inside your bones. It ...

Dave Coulier was diagnosed with stage 3 non-Hodgkin lymphoma after experiencing rapid lymph node swelling. Non-Hodgkin lymphoma affects the lymphatic system, with risk factors including age, gender, ...

Patients with a rare and aggressive type of blood cancer could soon have their chances of survival doubled as a groundbreaking trial to detect the disease earlier concludes. Scientists working on the ...

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...

Background: Transfusion-dependent bone marrow transplant recipients are routinely transfused with ABO group and RhD-compatible blood components. However, because of the scarcity of RhD-negative blood ...

The University of Utah Transplant and Cellular Therapy Program at Huntsman Cancer Institute and Primary Children's Hospital provides comprehensive, compassionate, state-of-the-art care for patients ...